TAMPA, FL / ACCESSWIRE / May 27, 2020 / On May 19, Arbitration Forums, Inc. (AF) welcomed Travelers to its growing list of member companies to adopt Settlement Exchange System® (SES®), AF's automated subrogation payment processing product.

Arbitration Forums, Inc. Logo

Elena Gervino, VP of Claim Legal and Specialized Services for Travelers, said, "We continually look for ways to better serve our customers. Settlement Exchange System makes our processes more efficient, and we're able to pass those savings on to our customers."

SES delivers substantial cost benefits and process efficiencies to members, with potential benefits to the industry in excess of $35M annually. SES facilitates both the automated issuance of electronic funds transfer (EFTs) and the processing of incoming subrogation and arbitration payments made via EFT once settlement is reached between members. Other than modest implementation-associated costs, SES is available to members at no charge.

SES features a payment aggregation option that allows netting of resolved claims among participants, reducing the number of payments between parties and providing participating companies the flexibility to determine the cadence of EFT payments and processing of incoming subrogation and arbitration recoveries.

Kathy Mahne, president and CEO for AF, said, "Given the current economic climate, it's more important than ever to help our members reduce costs and operate more effectively. SES does that. The implementation with Travelers, and the whole product really, is a great example of the collaboration between AF and its members. Through collaboration, as well as our innovative use of technology, we are able to create significant cost efficiencies and highly-accurate outcomes for our members."

The SES product originated as an extension of AF's E-Subro Hub® platform, the most widely used subrogation system. SES is now available for all subrogation and arbitration transactions. Nationwide, Enterprise, Allstate, and GEICO are already actively using SES to exchange subrogation payments. With the inclusion of Travelers, current SES companies issued 38% of E-Subro Hub demands YTD.

Founded in 1943, Arbitration Forums, Inc. is a membership-driven, not-for-profit organization that exists to effectively and efficiently serve its over 5,100 members' recovery and resolution needs. AF is the nation's largest arbitration and subrogation services provider. Annually, its members file over 953,000 arbitration disputes and almost 2 million subrogation demands collectively worth over $15.3 billion in claims.

AF is a membership-focused organization dedicated to providing its members with exceptional service and valuable solutions. AF ensures its members are at the center of everything AF does. AF embraces this member-centric mindset by implementing member feedback at all points of service.

The membership is the key driver of AF's future direction. Through their continued support, AF builds upon current successes and ensures its services continue to provide effective dispute resolution alternatives.

For more information, visit www.arbfile.org.

Media Contact:

Geoff Engert Director of Marketing, Compliance, and Legal
Phone: 813.915.2239
Email: gengert@arbfile.org

SOURCE: Arbitration Forums, Inc.

ReleaseID: 591466

HONG KONG / ACCESSWIRE / May 27, 2020 / Greenpro Capital Corp. (NASDAQ:GRNQ) today announced that it has signed a Sale and Purchase Agreement to acquire 4% of the Millennium Sapphire for US$4 million. The acquisition will be paid via the issuance of 4.44 million GRNQ restricted shares valued at $0.90 per share.

The two parties have 30 days to complete the acquisition. GRNQ is currently negotiating to buy the remaining 96% interest in the Millennium Sapphire into its wholly owned Wyoming subsidiary, Millennium Fine Arts, Inc.

About the Millennium Sapphire

The Millennium Sapphire is widely considered an icon in world of art and gems. It is one of the most documented gemstones of modern times. Since its discovery in Madagascar in 1995, this remarkable blue gem has appeared on CNN, BBC, NBC, FOX and numerous other television networks around the world. It has been written about in virtually every major newspaper and has been the subject of articles published in dozens of magazines, such as Forbes and others.

Independent gemological laboratory reports on the Millennium Sapphire include The Gemological Institute of America (GIA), Gubelin Gemological Laboratory, Switzerland, and the Asian Institute of Gemological Sciences (AIGS), Thailand. Additionally, the Millennium Sapphire was recognized in 2001 in the Guinness Book of records as the largest carved sapphire in the world at 61,500 carats.

World renowned gemologists have commented extensively on the Millennium Sapphire. "This crystal is the largest single piece of gem quality sapphire that I know of. It is very rare to see such a large piece of such good color," said Marcus McCallum, FGA, London. Garry Du Toit, now with the GIA, Bangkok said, "It is definitely gem grade sapphire, a fine gem blue color. Other famous blue sapphires can not compare in terms of size, weight and quite possibly color". And finally, Christian Dunaigre, formerly with the Gubelin Gemological Laboratory, Switzerland said, "This sapphire is everyone's dream".

In their report of 13 November 2000, Gubelin staff members Christopher P. Smith and Nicole Surdez commented: The Millennium Sapphire was an "ornately carved gem" and a "striking art object".

The Millennium Sapphire was a multi-year design and carving project directed by Italian artist and designer Alessio Boschi. Boschi's designs have been widely published and his art displayed in internationally respected venues such as the Metropolitan Museum of Art, New York, and he has won several international jewelry design competitions in Hong Kong, New York, Beijing, Madrid and London, including awards sponsored by Chopard and Charles Perroud S.A.

Boschi's inspiration for the Millennium Sapphire was to sculpt a tribute to the creative genius of humanity. Starting from a base of human figures supporting the four doors of air, water, earth and fire, the sapphire takes us on an upward winding spiral helix through history depicting over 134 figures representing the high points of man's achievements over the last 5000 years including the Pyramids of Giza, Confucius, Archimedes, the Great Wall of China, Julius Caesar, Mayan hieroglyphic writing, Leonardo da Vinci, Christopher Columbus, Michelangelo, Galileo, Newton, Bach, Mozart, Beethoven, Benjamin Franklin, Pasteur, Monet, Edison, Einstein, Charlie Chaplin, Louis Armstrong, Gandhi, Neil Armstrong, Mother Teresa and a host of others.

The Sapphire Sea, by John Robinson, a fictional novel, published in November 2003 was inspired by the discovery of the then unnamed Millennium Sapphire.

About the Millennium Sapphire Business

GRNQ plans to take the Millennium Sapphire on a world tour of museums around the world as well as to develop documentaries and include it in the plots of feature films. CEO CK Lee said, "We will develop the business and cash flows of the Millennium Sapphire through branding and licensing along with royalties and ticket sales through major museums worldwide. We are negotiating to acquire an art gallery business right now and we will retain some of the top art and promotions experts globally to develop and manage this amazing art treasure."

About Greenpro Capital Corp.

Headquartered in Hong Kong with strategic offices across Asia, Greenpro Capital Corp. (Nasdaq: GRNQ) is a multinational conglomerate with a diversified business portfolio comprising finance, technology, banking, CryptoSx for STOs, health and wellness, fine art, etc. With 30 years of experience in various industries, Greenpro has been assisting and supporting businesses and High-Net-Worth-Individuals to capitalize and securitize their value on a global scale through the provision of cross-border business solutions and accounting outsourcing services to small and medium-size businesses located in Asia. The comprehensive range of cross-border business services include, but are not limited to, trust and wealth management, listing advisory services, transaction services, cross-border business solutions, record management services, accounting outsourcing services and tax advisory services. We also operate venture capital businesses, including a business incubator for start-up and high growth companies, covering finance, technology, FinTech, and health and wellness. For further information regarding the Company, please visit http://www.greenprocapital.com.

Forward-Looking Statements

This press release contains forward-looking statements, particularly as related to, among other things, the business plans of the Company, statements relating to goals, plans and projections regarding the Company's financial position and business strategy. The words or phrases "plans," "would be," "will allow," "intends to," "may result," "are expected to," "will continue," "anticipates," "expects," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "think," "considers" or similar expressions are intended to identify "forward-looking statements." These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of local, regional, and global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

GRNQ has 54 million shares issued with 4.88 million shares in the float.

Contact:

Gilbert Loke, CFO, director
Greenpro Capital Corp.
Email: ir.hk@greenprocapital.com
Phone: +852-3111 7718

or

Dennis Burns. Investor Relations.
Email: dburns@nvestrain.com
Phone: (567) 237-4132‬

For more information on the Millennium Sapphire please visit:

www.millenniumsapphire.com

Facebook: millennium sapphire

SOURCE: Greenpro Capital Corp.

ReleaseID: 591413

New Software Allows Dispensaries to Adapt to Local Guidelines and Expand their Marketing Reach

DENVER, CO / ACCESSWIRE / May 27, 2020 / Leafbuyer Technologies, Inc. ("Leafbuyer" or "the Company") (OTCQB:LBUY), a leading cannabis technology platform, announced today the launch of a web application solution that allows dispensaries to offer pickup and delivery options from their own websites.

"This technology aligns with the current social distancing requirements affecting dispensaries as well as the overall retail trend of moving to online ordering solutions," said Kurt Rossner, CEO of Leafbuyer. "We are excited to integrate this online ordering technology tool with our enterprise texting tool. Providing useful software solutions to our dispensary customers remains a top priority for Leafbuyer and our mission to be the cannabis industry technology leader. Creating industry-leading technology for modern dispensaries is the key to Leafbuyer's path to profitability."

"As the cannabis industry matures in markets across the country, dispensaries are increasingly focused on controlling the entire customer experience," stated Rossner. "These sophisticated brands are driving traffic to their websites where they can capture customer information and receive orders. Leafbuyer is positioned to capitalize on this trend by offering plug-and-play online ordering solutions combined with our texting and loyalty platform."

Once a dispensary installs the simple embed code on their website, the ordering widget will display the menu. For dispensaries who use the major point-of-sale platforms, Leafbuyer will provide a real-time menu through live integrations. Within seconds, customers can place an order for pickup or delivery from desktop or mobile devices. Amidst the COVID-19 crisis, dispensaries are increasingly seeking out pickup and delivery options to offer their customers.

This web application further establishes Leafbuyer as a viable software solution for cannabis delivery. Consumers can place an order for cannabis products to be delivered from a participating dispensary much the same way a person can order a pizza through a mobile application.

Another major feature is that the application provides dispensary customers real-time order notifications. For pickup orders, customers receive notifications when the order has been received by the dispensary, when the order is ready for pickup, and other important reservation details. Notifications for delivery orders provide the customer additional details such as estimated delivery time, when the delivery is in route, and when the delivery has been completed.

About Leafbuyer Technologies, Inc.

Leafbuyer Technologies is one of the most comprehensive technology and communication software providers for the cannabis industry. Leafbuyer.com is an all-inclusive online resource for cannabis deals and information. Leafbuyer works alongside businesses to showcase their unique products and build a network of loyal patrons. Leafbuyer's national network of cannabis deals and information reaches millions of consumers every month. Leafbuyer is the official cannabis deals platform of Dope Media, Sensi Magazine, and Voice Media Group.

Learn more at Leafbuyer.com

Contacts

Leafbuyer Technologies, Inc.
Andre Leonard, +720-432-5593
aleonard@leafbuyer.com

Cautionary Statement Regarding Forward-Looking Information

Safe Harbor Statement

This press release may contain forward-looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC). Actual results and the timing of certain events could differ materially from those projected in the forward-looking statements due to several factors detailed from time to time in our filings with the Securities and Exchange Commission. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC filings.

SOURCE: Leafbuyer Technologies, Inc. 

ReleaseID: 591577

BIRMINGHAM, AL / ACCESSWIRE / May 27, 2020 / London-LSE quoted Diversified Gas & Oil Plc (LSE:DGOC), "DGO" or the "Company"), the U.S. based owner and operator of natural gas, natural gas liquids, and oil wells as well as midstream assets, confirms that further to the announcements made by the Company on April 8, 2020 and May 12, 2020, it has completed the purchase of certain upstream and midstream assets from Carbon Energy Corporation ("Carbon") (the "Acquisition"). Concurrent with the Acquisition, DGO also closed on a 10-year amortizing $160 million gross senior secured term loan ($155 million net of fees and a $3 million interest and principal reserve account) underwritten and funded by Munich Re Reserve Risk Financing, Inc. ("MRRF") that includes a 6.5% fixed coupon and a 10-year hedge portfolio to stabilize cash flows (the "Financing").

Acquisition Highlights:

PDP reserves of ~74 MMBoe (444 Bcfe) with pretax PV10 of ~$189 million on recent NYMEX strip
Estimated next twelve months Adjusted EBITDA of ~$29-$31 million
Net consideration represents a 3.2x-3.4x cash multiple
~9,100 Boepd (~54,600 Mcfe) of adjusted 2019 net production (~97% gas)
Average 92% working interest / 82% net revenue interest
~6,100 net conventional wells with an average decline rate of ~4%/year
~4,700 miles of midstream providing flow optionality and margin-enhancing opportunities:

Significant future cost and operational optimization opportunities with >200 common intersects with existing DGO gathering systems
Direct connections to favorably priced interstate pipelines
Revenue-generating opportunities with direct connections to large commercial/industrial and utility customers as well as two active gas storage fields with ~3.5 Bcf of working capacity

Immediate realizable synergies in field operating expenses and G&A achieved by retaining ~80% of existing Carbon workforce
Inclusive of the assets acquired from both Carbon and EQT Corporation ("EQT"), DGO's average daily net production is 112 Mboepd

For the Acquisition and at closing, DGO paid net consideration of approximately $98 million ($110 million, gross) after customary purchase price adjustments with a January 1, 2020 effective date. Depending on future natural gas prices and measured on an annual basis over the next three years, Carbon may earn additional contingent consideration of up to $15 million in aggregate if actual NYMEX natural gas prices exceed certain established thresholds. Based on forward NYMEX natural gas prices at the time of closing, total estimated contingent consideration is less than $5 million.

The Financing:

Using the Financing proceeds, DGO funded the Acquisition and repaid the short-term draw on its revolving credit facility used to fund a portion of the EQT asset acquisition announced on May 26, 2020. DGO collateralized the Financing primarily with working interest in certain of its newly acquired upstream assets and related landholdings from EQT and Carbon (together, the "Collateral Assets"). As with the Company's previous securitized financing transactions, DGO created a wholly owned and fully consolidating special purpose vehicle ("SPV") to hold the Collateral Assets, which DGO will operate.

The Financing represents the Company's second transaction with MRRF, the sole investor in the Company's inaugural $200 million asset-backed securitized financing arrangement completed in November 2019. Combined, MRRF has underwritten and funded $360 million (gross) since November 2019, validating the quality of the Company's assets, cash flows and operating capabilities.

Financing Highlights:

6.5% coupon
10-year amortizing repayment
No corporate covenants or recourse outside the SPV
10-year hedge protection on specified volumes

Hedged volumes are shaped to fit the natural expected production decline from the assets over time
Swap prices of $2.20/MMBtu for the remainder of 2020 and $2.70/MMBtu and $2.65/MMBtu in 2021 and 2022, respectively
DGO will post an updated hedge supplement to its website in due course that reflects the entire hedge portfolio

Following the Financing, ~70% of DGO's debt now sits in long-term, fixed rate, amortizing structures through 2030 underpinned with long-term hedges and no redetermination risk and lessens DGO's reliance on its revolving credit facility during this period of heightened market volatility. The long-term Financing aligns with DGO's long-life assets, and its amortizing structure demonstrates commitment to continuous debt reduction while eliminating future "bullet payments" along with the associated refinancing risk.

Immediately following the Acquisition and Financing, the Company's consolidated net debt-to-Adjusted EBITDA approximates 2.3x. Additionally, DGO's total liquidity now approximates $213 million, inclusive of cash and availability on its revolving credit facility. The Company's liquidity reflects the impact of less cash needed at closing due to a larger than originally estimated downward purchase price adjustment for both acquisitions' effective date of January 1, 2020. DGO's borrowing base on its revolving credit facility remains $425 million as the Company begins working with its bank group to complete its semi-annual redetermination process during June 2020.

Commenting on the acquisition, Rusty Hutson, Jr., CEO of the Company said:

"Today's transactions continue our commitment to create long-term shareholder value through selective expansion of our upstream and strategically important midstream assets. Like our largely conventional legacy assets, Carbon's wells display the same long-life, low-decline profile and expand our base of stable production and Smarter Well Management opportunities. To that end, we welcome the members of Carbon's team who today join the Diversified family and partner with us to realize the full, combined potential of these wells and the complementary midstream assets. I would also like to thank Munich Re Reserve Risk Financing, Inc. for their commitment to fund our acquisition of assets from EQT and Carbon, increasing their total investment in Diversified to $360 million during a time when many lenders are reducing their exposure to the sector. We share a common belief in the low-risk profile and high-quality nature of the underlying assets and their associated cash flows, and believe this amortizing financing, in concert with proceeds from our successful equity fundraising, further demonstrates our commitment to maintain a healthy balance sheet and appropriate leverage profile relative to the strength, reliability and visibility of our cash flow."

Company Contact: Teresa Odom, VP Investor Relations | IR@dgoc.com | 205.408.0909

SOURCE: Diversified Gas & Oil PLC

ReleaseID: 591528

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the Jefferies 2020 Virtual Global Healthcare Conference on Thursday, June 4, 2020 at 4:00 p.m. ET.

A live audio webcast of the presentation may be accessed on the Investors section of the Kadmon website at www.kadmon.com. A replay of the webcast will be available for 90 days.

About Kadmon

Kadmon is a biopharmaceutical company developing innovative products for significant unmet medical needs. Our product pipeline is focused on inflammatory and fibrotic diseases as well as immuno-oncology.

Forward Looking Statements

This press release contains forward-looking statements. Such statements may be preceded by the words "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "targets," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We believe that these factors include, but are not limited to, (i) the impact of COVID-19 on our ability to conduct our business or our clinical trials, (ii) the initiation, timing, progress and results of our preclinical studies and clinical trials, and our research and development programs; (iii) our ability to advance product candidates into, and successfully complete, clinical trials; (iv) our reliance on the success of our product candidates; (v) the timing or likelihood of regulatory filings and approvals, including an NDA regarding belumosudil (KD025); (vi) our ability to expand our sales and marketing capabilities; (vii) the commercialization of our product candidates, if approved; (viii) the pricing and reimbursement of our product candidates, if approved; (ix) the implementation of our business model, strategic plans for our business, product candidates and technology; (x) the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology; (xi) our ability to operate our business without infringing the intellectual property rights and proprietary technology of third parties; (xii) costs associated with defending intellectual property infringement, product liability and other claims; (xiii) regulatory developments in the United States, Europe, China, Japan and other jurisdictions; (xiv) estimates of our expenses, future revenues, capital requirements and our needs for additional financing; (xv) the potential benefits of strategic collaboration agreements and our ability to enter into strategic arrangements; (xvi) our ability to maintain and establish collaborations or obtain additional grant funding; (xvii) the rate and degree of market acceptance of our product candidates; (xviii) developments relating to our competitors and our industry, including competing therapies; (xix) our ability to effectively manage our anticipated growth; (xx) our ability to attract and retain qualified employees and key personnel; (xxi) the use of proceeds from our recent public offerings; (xxii) the potential benefits of any of our product candidates being granted orphan drug designation; (xxiii) the future trading price of the shares of our common stock and impact of securities analysts' reports on these prices; and/or (xxiii) other risks and uncertainties. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), including Kadmon's Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and subsequent Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Contact Information

Ellen Cavaleri, Investor Relations
646.490.2989
ellen.cavaleri@kadmon.com

SOURCE: Kadmon Holdings, Inc.

ReleaseID: 591564

New Commercial Offering Enables Data Suppliers to Leverage Crux's Ready-Made Infrastructure to Expand Delivery Methods, Accelerate Trials and Onboard Clients

NEW YORK, NY / ACCESSWIRE / May 27, 2020 / With the proliferation of financial data and cloud technologies, customer requirements to ingest and analyze data are diversifying and evolving fast. Driven by data suppliers' demand to leverage its ready-made infrastructure and services, Crux Informatics (Crux) today unveiled a new offering, Crux Deliver, expanding its platform to help data suppliers improve their delivery capabilities. This turnkey, managed service provides powerful technology capabilities to support delivery expansion for suppliers at a fraction of the cost of developing their own infrastructure.

"From exchanges to alternative data providers, suppliers need to rely on a platform to deliver data quickly and at scale, rather than taking time and resources to build their own at a high cost," said Michael Rude, head of go-to-market at Crux. "Our Crux Deliver offering is a turnkey solution that enables suppliers to deliver data to their customers in more formats, via more delivery methods, and with more tools. Most importantly, it reduces future technology burdens and provides an operations team to execute everything on their behalf at an affordable price."

Following the explosion of data over the last five years, consumer preferences and architectures around file formats and delivery methods have diversified greatly. Most suppliers currently have just one file format (e.g. CSV) and one delivery method (e.g. FTP) for their clients. Crux Deliver immediately broadens their reach with multiple file formats (e.g. Avro, CSV, Parquet) and delivery methods (e.g. API, cloud warehouse integrations, SQL, ODBC) already built and maintained by Crux.

Crux Deliver consists of five main capabilities for suppliers:

A strong partner to expand their delivery and operational reach for any data product, ingested and delivered in any data format preferred by supplier or client;
Managed delivery of supplier data through various methods to suit client needs, including REST API, Python client, S/FTP, SQL queries, ODBC connectivity, or automatic data upload into Amazon S3, Google Cloud Platform, Microsoft Azure, or Snowflake;
Distribution into data marketplaces, including data delivery and profile management on the AWS Data Exchange and the Snowflake Data Marketplace;
Monitoring and support from Crux specialists to validate data and ensure that no inconsistencies or unforeseen changes reach their clients;
Access to metadata catalog for clients – The Crux Discover app provides users powerful search capabilities that help them easily find, understand, request access to, and ultimately use supplier's data.

"Access to Crux Discover and our querying capabilities are in high demand from supplier and consumer clients alike," said Rude. "Never has it been easier for users to efficiently browse their catalog of metadata and quickly query supplier datasets through one central platform."

Crux Deliver offers a no-risk, plug and play model to quickly begin delivering to customers. Crux remains a neutral partner that plugs directly into suppliers' existing workstreams and delivers to clients on the supplier's behalf. Crux does not disintermediate existing data licenses with consumers. It simply carries a small delivery fee per dataset.

Crux Deliver ensures suppliers stay "future-proof," ahead of developing trends, with robust infrastructure, strong technology industry partnerships and a world-class data operations team. The Crux Deliver managed service is already used by leading data providers including Euronext FX.

About Crux Informatics

Crux Informatics helps data consumers and data suppliers accelerate delivery of any data product, in any format, to any end-customer destination. Its Crux Deliver managed service offers a simple, reliable and affordable solution to expand delivery and operations of their data products to customers. With ready-made API, cloud warehouse integrations, querying capabilities, and operational support teams, data suppliers can leverage Crux infrastructure to scale the complex and resource intensive process of delivering data and help prevent sending data with potential errors to customers.

Visit www.cruxinformatics.com
Contact data@cruxinformatics.com

SOURCE: Crux Informatics

ReleaseID: 591521

DURHAM, NC / ACCESSWIRE / May 27, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company specialized in the development of novel therapeutic and prophylactic vaccines, including one for coronavirus COVID-19, announced that it is collaborating with Waisman Biomanufacturing to establish a partnership for the manufacture of Heat's COVID-19 vaccine.

Waisman specializes in the manufacture of cellular therapeutics and other biologics for early-stage clinical trials and is part of the University of Wisconsin (Madison, Wisconsin). It has manufactured over 320 clinical grade products, earning a reputation for cost-effective and timely production of quality biologics.

Heat Biologics previously worked with Waisman to manufacture Heat's HS-130, which is currently in a Phase 1 clinical trial, and is collaborating with Waisman to support the manufacturing of its COVID-19 vaccine for expected Phase 1 trials in humans. The vaccine leverages Heat's proprietary gp96 platform to target the SARS-CoV-2 coronavirus that causes COVID-19. Heat's unique approach is designed to induce a multi-epitope specific memory CD8 T-cell response that protects against multiple, distinct coronavirus strains and against potential future mutations of SARS-CoV-2 and other coronaviruses.

Jeff Wolf, Chief Executive Officer of Heat, stated, "We continue to advance our COVID-19 vaccine and are pleased to be working with Waisman to assist our manufacturing efforts. We remain encouraged by the potential of our platform to provide broad protection against COVID-19, particularly for elderly patients and those with underlying health conditions that have an increased risk of complications and death from COVID-19. Our confidence is reinforced by numerous National Institutes of Health (NIH) and U.S. Department of Defense (DOD)-funded mice and primate trials utilizing our gp96 platform to generate vaccines against SIV/HIV, malaria, zika and other infectious diseases. These trials have demonstrated gp96 is a powerful platform with antiviral activity in the lungs, as evidenced by a potent immune response and effectiveness in the induction of mucosal immunity in several infectious disease models."

Carl Ross, Managing Director of Waisman Biomanufacturing, commented, "We are honored to partner with Heat again on the development of this very unique COVID-19 approach. We believe our unique capabilities and expertise, as well as the experience that we gained working with Heat to manufacture their HS-130, which is based upon the same gp96 platform, will help further the manufacturing timeline for this potentially life-saving COVID-19 vaccine."

About Heat Biologics, Inc.

Heat Biologics is a biopharmaceutical company developing immunotherapies designed to activate a patient's immune system against cancer and other diseases using its proprietary gp96 platform to activate CD8+ "Killer" T-cells. Heat has completed enrollment in its Phase 2 clinical trial for advanced non-small cell lung cancer with its gp96-based HS-110 therapeutic vaccine. HS-110 is the company's first biologic product candidate in a series of proprietary immunotherapies designed to stimulate a patient's own T-cells. Heat Biologics has also launched a program in collaboration with the University of Miami to develop a vaccine designed to protect against the COVID-19 Coronavirus. Heat has numerous other pre-clinical programs at various stages of development. For more information, please visit www.heatbio.com.

Forward Looking Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 on our current expectations and projections about future events. In some cases, forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectation, and assumptions and include statements such as Heat collaborating with Waisman to support the manufacturing of its COVID-19 vaccine for expected Phase 1 trials in humans, the potential of Heat's platform to provide broad protection against COVID-19, particularly for elderly patients and those with underlying health conditions that have an increased risk of complications and death from COVID-19, Waisman's unique capabilities and expertise, as well as the experience that it gained working with Heat to manufacture their HS-130 helping further the manufacturing timeline for the potentially life-saving COVID-19 vaccine.. These statements are subject to a number of risks and uncertainties, many of which are difficult to predict, including the ability of Heat to develop a proprietary COVID-19 vaccine, the ability to accelerate the manufacturing timeline for the potentially life-saving COVID-19 vaccine, , the ability of Heat's therapies to perform as designed, to demonstrate safety and efficacy, as well as results that are consistent with prior results, the ability to enroll patients and complete the clinical trials on time and achieve desired results and benefits, Heat's ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating to Heat's ability to promote or commercialize its product candidates for specific indications, acceptance of its product candidates in the marketplace and the successful development, marketing or sale of products, Heat's ability to maintain its license agreements, the continued maintenance and growth of its patent estate, its ability to establish and maintain collaborations, its ability to obtain or maintain the capital or grants necessary to fund its research and development activities, its ability to continue to maintain its listing on the Nasdaq Capital Market and its ability to retain its key scientists or management personnel, and the other factors described in Heat's most recent annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC, and other subsequent filings with the SEC. The information in this release is provided only as of the date of this release, and Heat undertakes no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.

Media and Investor Relations Contact

David Waldman
+1 919 289 4017
investorrelations@heatbio.com

SOURCE: Heat Biologics, Inc.

ReleaseID: 591559

LAS VEGAS, NV / ACCESSWIRE / May 27, 2020 / Alkame Holdings, Inc. (OTC PINK:ALKM), a publicly-traded holding company, announced today that as part of its continued growth and expansion it has launched its new wholly-owned specialty manufacturing subsidiary, West Coast Co Packer, Inc.

West Coast Co Packer, Inc. is a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract packager and is expected to immediately complement and seamlessly integrate with Alkame's other subsidiaries including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty natural, organic liquid-based hot and cold fill food & beverage manufacturer in glass and PET bottles and jars.

West Coast Co Packer, Inc. will immediately provide Alkame Holdings, Inc. with the capability of co-packing while now being able to offer additional production and packaging options not offered before. West Coast Co Packer, Inc. will enter a new market for portable, single-serve packaging options to provide an additional eco-friendly and easy-to-use alternative to traditional bulk-serve packaging.

According to Robert Eakle, CEO, "We look forward to this expansion that will immediately generate additional revenue and afford us the opportunity to bring in additional production equipment. Now with this added equipment, we are poised to offer our clients an array of co-packing options that we couldn't do before. It is our intent to become a ‘one-stop-shop' to meeting all our client's needs.

West Coast Co Packer, Inc. will now have the capability to provide clients with liquid and in the near future, dry packages in stick packs, pouches, and sachets. Drinks such as sports drinks drink mixes; tea, protein, coffee, and a variety of other liquid or powered drink products work well with this type of packaging.

About Alkame Holdings, Inc.

Alkame Holdings, Inc. is a publicly-traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries manufacture products with enhanced water utilizing proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications by placement into several emerging business sectors, such as consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, hand sanitizers, and many other various water-based treatment solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com

CONTACT:
Tony Schor
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com

Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

SOURCE: Alkame Holdings, Inc

ReleaseID: 591477

VANCOUVER, BC / ACCESSWIRE / May 27, 2020 / Makara Mining Corp. (CSE:MAKA)(Frankfurt:MK0) ("Makara" or the "Company") is pleased to announce the appointment of C. Hugh Maddin as a member of its Board of Directors. Mr. Maddin is a member of the Law Society of British Columbia and has been an active member of the B. C. business community for over 20 years. He is an executive and director of several public companies and Chairman and CEO of a number of private resource companies. He is the sole shareholder, President and CEO of Cambrian Capital Corp., a private investment holding company. As a practicing lawyer and entrepreneur, Mr. Maddin brings much experience in corporate, commercial, mining finance, venture capital, real estate and mining projects.

About the Company

The Company is a mineral exploration company focused on the acquisition, exploration and development of gold properties. The Company is based in Vancouver, B.C and holds an option over the Rude Creek Property located in the Yukon and Kenora Gold Property located in Northwestern Ontario.

For more information, investors should review the Company's filings that are available at www.sedar.com.

Forward Looking Statements

This news release contains certain forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance are "forward-looking statements.". Forward-looking statements are subject to a number of risks and uncertainties, including those detailed from time to time in filings made by the Company with securities regulatory authorities, which may cause actual outcomes to differ materially from those discussed in the forward-looking statements. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Contact Information

Grant Hendrickson
Director and Chief Executive Officer
Telephone: 604-372-3707
Email: grant@makaramining.com

SOURCE: Makara Mining Corp.

ReleaseID: 591540

Not for Distribution to United States Newswire Services or for Dissemination in the United States.

VANCOUVER, BC / ACCESSWIRE / May 27, 2020 / Mawson Resources Limited ("Mawson" or the "Company") (TSX:MAW)(Frankfurt:MXR)(OTC PINK:MWSNF) is pleased to announce that it has closed its previously announced non-brokered private placement financing (Mawson News Releases May 11, 2020) (the "Offering") for gross proceeds of C$1,001,000.

A total of 2,860,000 units (the "Units") of the Company, were issued at a price of C$0.35 per Unit. Each Unit consisted of one (1) common share ("Common Share") of the Company and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Warrant"). Each Warrant will entitle the holder thereof to acquire one Common Share of the Company at a price of C$0.45 until May 27, 2022.

The Company intends to use the net proceeds from the Offering for exploration on the Company's exploration properties and for working capital and general corporate purposes. All securities issued in connection with the Offering are subject to a statutory four-month hold period expiring on September 28, 2020.

The securities offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Units, Common Shares or Warrants in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

About Mawson Resources Limited (TSX:MAW, FRANKFURT:MXR, PINKSHEETS:MWSNF)

Mawson Resources Limited is a gold exploration and development company. Mawson has distinguished itself as a leading Nordic Arctic exploration company with a focus on the flagship Rajapalot gold-cobalt project in Finland. The recent acquisition in the Victorian goldfields of Australia provides Mawson with a strategic and diversified portfolio of high-quality gold exploration assets in two tier one and safe jurisdictions.

On behalf of the Board,

"Michael Hudson"
Michael Hudson, Chairman & CEO

Further Information
www.mawsonresources.com
1305 – 1090 West Georgia St., Vancouver, BC, V6E 3V7 (Canada)
Mariana Bermudez, Corporate Secretary, +1 (604) 685 9316,
info@mawsonresources.com

Forward-Looking Statement

This news release contains forward-looking statements or forward-looking information within the meaning of applicable securities laws (collectively, "forward-looking statements"). All statements herein, other than statements of historical fact, are forward-looking statements. Although Mawson believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: believe, expect, anticipate, intend, estimate, postulate, and similar expressions, or are those, which, by their nature, refer to future events. Mawson cautions investors that any forward-looking statements are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors, including, but not limited to, the proposed use of the net proceeds of the Offering varying from expectations, the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company's business, operations and financial condition, capital and other costs varying significantly from estimates, changes in world metal markets, changes in equity markets, planned drill programs and results varying from expectations, delays in obtaining results, equipment failure, unexpected geological conditions, local community relations, dealings with non-governmental organizations, delays in operations due to permit grants, environmental and safety risks, and other risks and uncertainties disclosed under the heading "Risk Factors" in Mawson's most recent Supplement and Base Shelf Prospectus, and the documents incorporated therein, filed on www.sedar.com. Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Mawson disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise.

SOURCE: Mawson Resources Limited

ReleaseID: 591571